Weight loss plateau on Mounjaro: what to do when the scales stop moving

Is this actually a plateau, or is it the body doing something normal?

The first question worth asking is how long the stall has lasted. Weight rarely falls in a straight line. A single week where the number on the scale does not shift can reflect water retention, hormonal fluctuations, a change in bowel habit, any of the normal biological noise that has nothing to do with Mounjaro's effectiveness. Most clinicians start treating a stall as a true plateau only once it has persisted for three to four consecutive weeks despite consistent treatment and broadly stable habits.

It is also worth noting what the scale measures versus what is changing. Early in treatment, as appetite falls and food volume drops, some people lose muscle mass alongside fat. If you have added strength training, muscle tissue is denser than fat, the body composition may be improving even when the number barely moves. A tape measure around the waist often tells a more complete story at this stage than the scale alone.

Understanding how Mounjaro plateaus typically develop is the starting point for deciding what, if anything, needs to change. The short version: a genuine, multi-week stall that coincides with no dose increase and no major lifestyle shift is the pattern that usually warrants action.

The three levers you actually control

Once a real plateau is confirmed, the response almost always comes down to three areas: what you are eating, how you are moving, and whether your current dose is still doing its job.

On nutrition: Mounjaro suppresses appetite strongly, and many people eating much less than before, sometimes so much less that total protein intake has fallen too low. Protein supports muscle retention and has a higher thermic effect than fat or carbohydrate, meaning the body burns more calories processing it. A rough target of 1.2–1.6 g of protein per kilogram of body weight is consistent with NHS Live Well guidance on diet alongside weight management. Getting enough protein becomes harder when portions are small, so it helps to prioritise it at each meal rather than treating it as an afterthought.

On activity: weight loss itself lowers the metabolic rate, because a lighter body burns fewer calories at rest. Resistance exercise is one of the few reliable tools for partially offsetting that adaptation. Even two sessions a week (bodyweight exercises, resistance bands, weights) can preserve muscle and nudge the metabolic rate back up. That is a practical, time-efficient lever that does not require a gym membership.

On dose: if you are not yet at your maintenance dose and the plateau has lasted several weeks, a dose increase may be what the prescriber recommends. The schedule runs in 2.5 mg steps; the prescriber assesses your tolerability at the current level before moving up. That is not a decision to make independently. The timeline for Mounjaro to produce meaningful weight loss varies by individual and by dose, which is why clinical review matters at every stage.

The role of sleep, stress and consistency

Two factors that patients often underestimate are sleep quality and cortisol load. Poor sleep raises ghrelin (the hormone that drives hunger) and lowers leptin (the one that signals fullness), which is the opposite of what Mounjaro is working to achieve. Cortisol from sustained stress triggers the body to retain fat, particularly around the abdomen, and can blunt the weight-loss response even when the medicine is working as expected.

Consistency matters more than perfection here. One useful check: is the pen actually being stored correctly? Mounjaro pens need to be kept in the fridge at 2–8°C (the fridge door works well as a visual reminder) because exposure to temperatures outside that range can affect how the medicine performs. The NHS medicines guidance on tirzepatide covers storage in detail; when in doubt, the Patient Information Leaflet is the definitive reference.

For a broader look at what drives a Mounjaro plateau and how long they typically last, our clinical team has put together a more detailed guide. It is worth reading alongside this page if the stall has been going on for more than a month.

When to raise it with your prescriber

Not every plateau needs a clinical response, but some do. Speak to your prescriber if: the stall has lasted more than four weeks despite consistent treatment; you are experiencing side effects that are affecting your ability to eat a balanced diet; you are considering taking a break from treatment. A planned break from Mounjaro is a clinical decision, not simply a lifestyle choice, the implications of pausing treatment are worth understanding before you stop.

The NICE appraisal of tirzepatide (NICE TA1026) includes a review threshold: if less than 5% of body weight has been lost after six months at the highest tolerated dose, the clinical team reviews whether continuing is appropriate. That is the formal benchmark. In practice, plateaus that occur earlier in treatment (at lower doses, or during an otherwise positive response) rarely meet that threshold and are usually managed with dose adjustment or lifestyle support rather than discontinuation.

If you want to look at your treatment as a whole, the tirzepatide plateau guide covers the clinical evidence behind why stalls happen and what the data shows about long-term weight loss trajectories. You can also review the cost of Mounjaro treatment if you are weighing up how to continue. For a clinical conversation about your specific situation, speak to our prescribers, a named clinician, not a decision tree, will review your case.